These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2932460)

  • 1. Peripheral serotonin2 receptor blockade does not inhibit 5-hydroxytryptophan-induced aldosterone stimulation.
    Shenker Y; Gross MD; Grekin RJ
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1201-4. PubMed ID: 2932460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central serotonergic stimulation of aldosterone secretion.
    Shenker Y; Gross MD; Grekin RJ
    J Clin Invest; 1985 Oct; 76(4):1485-90. PubMed ID: 2997280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa.
    Williams BC; Shaikh S; Edwards CR
    J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin regulation of aldosterone secretion.
    Maestri E; Camellini L; Rossi G; Rossi GP; Dotti C; Marchesi M; Gnudi A
    Horm Metab Res; 1988 Jul; 20(7):457-9. PubMed ID: 2844641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat.
    Yap CY; Taylor DA
    Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism by ketanserin of the behavioral effects of quipazine but not l-5-hydroxytryptophan in squirrel monkeys.
    Witkin JM; Brady LS; Barrett JE
    Psychopharmacology (Berl); 1988; 94(3):302-5. PubMed ID: 3128804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotoninergic stimulation of aldosterone secretion in the rat in vivo: role of the renin-angiotensin system.
    Davies E; Rossiter S; Edwards CR; Williams BC
    J Endocrinol; 1991 Sep; 130(3):347-55. PubMed ID: 1719114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotoninergic stimulation of aldosterone secretion in vivo: role of the hypothalamo-pituitary adrenal axis.
    Davies E; Rossiter S; Edwards CR; Williams BC
    J Steroid Biochem Mol Biol; 1992 Mar; 42(1):29-36. PubMed ID: 1373072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO; Eyre P
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ketanserin in primary aldosteronism.
    Mantero F; Rocco S; Opocher G; Armanini D; Boscaro M; D'Agostino D
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S172-5. PubMed ID: 2412045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan.
    Alhaider AA; Mustafa AA
    Psychopharmacology (Berl); 1991; 103(3):351-6. PubMed ID: 1647538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets.
    Lampugnani MG; de Gaetano G
    Biochem Pharmacol; 1982 Sep; 31(18):3000-2. PubMed ID: 7138588
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ketanserin, a new inhibitor of 5-HT2 receptors, on plasma renin activity and aldosterone levels in normal subject.
    Degli Uberti EC; Trasforini G; Margutti AR; Rotola CA; Pansini R
    Horm Res; 1982; 16(4):244-8. PubMed ID: 6751979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
    Jandhyala BS; Kivlighn SD
    Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonin-4 receptor agonist cisapride and angiotensin-II exert additive effects on aldosterone secretion in normal man.
    Lefebvre H; Contesse V; Delarue C; Legrand A; Kuhn JM; Vaudry H; Wolf LM
    J Clin Endocrinol Metab; 1995 Feb; 80(2):504-7. PubMed ID: 7852511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of ketanserin, atropine and methysergide on the gastrointestinal effects of hyperserotoninemia in the awake dog.
    Jaffe BM; Ferrara A; Sherlock DJ
    J Pharmacol Exp Ther; 1986 Aug; 238(2):536-41. PubMed ID: 2942678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of action of ketanserin, a selective antagonist of the S2 receptors with antihypertensive activity.
    Rión R; Mena MA; Hong E
    Proc West Pharmacol Soc; 1983; 26():373-5. PubMed ID: 6889366
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of serotonin antagonists in a behavioral despair procedure in mice.
    Luttinger D; Freedman M; Hamel L; Ward SJ; Perrone M
    Eur J Pharmacol; 1984 Dec; 107(1):53-8. PubMed ID: 6526071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.